State Health Care Accreditation Agency
The State Accreditation Service for Health Care Activities under the Ministry of Health (VASPVT) was established in 1996 to accredit healthcare institutions and organize medical product approvals. Since 2003, VASPVT has expanded its functions to include licensing, accreditation, and laboratory certification of personal health care institutions.
It has also been responsible for conformity assessment of medical devices, market supervision, and patient safety. VASPVT has also organized evaluations of health care technologies, issued licenses for public health care activities, and participated in joint-international evaluations of medical devices. The service has launched various initiatives to combat illegal activities and improve the quality of healthcare services.
https://vaspvt.gov.lt/node/107
Medical Devices Regulation
Class I, IIa, IIb and III
Registration form for medical devices (devices) placed on the market and submit the relevant documents specified in the form
Indefinite
Labeling information must be submitted in Lithuanian, regardless of the level of competence of the end user
On April 5, 2017, two new Regulations on medical devices were adopted, these entered into force on May 25, 2017, and replaced the existing Directives. The new rules will only apply after a transitional period, namely, 3 years after entry into force for the Regulation on medical devices (spring 2020) and 5 years after entry into force (spring 2022) for the Regulation on in vitro diagnostic medical devices.
Manufacturers of class IIa, IIb and III medical devices and custom made active implantable medical devices must notify the Accreditation Agency when these devices are placed on the market in Lithuania. Alternatively, their authorized representatives or their authorized distributors must notify the Accreditation Agency.
Lithuanian manufacturers or authorized representatives who have registered place of business in Lithuania must notify Accreditation Agency about the first placing on the market of:
Before placing a medical device into the market.
On April 5, 2017, two new Regulations governing medical devices were adopted, coming into force on May 25, 2017, and replacing existing Directives. The application of these new rules is scheduled after specific transitional periods – 3 years after entry into force for the Regulation on medical devices (spring 2020) and 5 years after entry into force (spring 2022) for the Regulation on in vitro diagnostic medical devices.
Manufacturers of class IIa, IIb, and III medical devices, along with custom-made active implantable medical devices, are required to notify the Accreditation Agency when placing these devices on the market in Lithuania. Alternatively, authorized representatives or authorized distributors can fulfill this notification obligation on behalf of the manufacturers.
Lithuanian manufacturers or authorized representatives with registered places of business in Lithuania must notify the Accreditation Agency about the first placement on the market of:
Act as your Authorized representative
Contact us for free consultation: info@omcmedical.co.uk
Our team will be happy to respond your queries. Contact us directly with your questions or for scheduling FREE consultation and we’ll be in touch as soon as possible.
Our team will be happy to respond your queries. Contact us directly with your questions or for scheduling FREE consultation and we’ll be in touch as soon as possible.
Our team will be happy to respond your queries. Contact us directly with your questions or for scheduling FREE consultation and we’ll be in touch as soon as possible.
To launch a medical device in a country, medical devices must comply with the local country’s regulatory requirements. Let us be your trusted partner in bringing your medical devices to the Global market. Contact us today to learn more about how we can assist you in every step of the way.
This will close in 0 seconds